These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 27790375)

  • 1. Novel heterozygous mutation in the extracellular domain of
    Takagi M; Miyoshi T; Nagashima Y; Shibata N; Yagi H; Fukuzawa R; Hasegawa T
    Hum Genome Var; 2016; 3():16034. PubMed ID: 27790375
    [TBL] [Abstract][Full Text] [Related]  

  • 2. FGFR1 mutations cause Hartsfield syndrome, the unique association of holoprosencephaly and ectrodactyly.
    Simonis N; Migeotte I; Lambert N; Perazzolo C; de Silva DC; Dimitrov B; Heinrichs C; Janssens S; Kerr B; Mortier G; Van Vliet G; Lepage P; Casimir G; Abramowicz M; Smits G; Vilain C
    J Med Genet; 2013 Sep; 50(9):585-92. PubMed ID: 23812909
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel synonymous and missense variants in FGFR1 causing Hartsfield syndrome.
    Courage C; Jackson CB; Owczarek-Lipska M; Jamsheer A; Sowińska-Seidler A; Piotrowicz M; Jakubowski L; Dallèves F; Riesch E; Neidhardt J; Lemke JR
    Am J Med Genet A; 2019 Dec; 179(12):2447-2453. PubMed ID: 31512363
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel de novo heterozygous FGFR1 mutation in two siblings with Hartsfield syndrome: a case of gonadal mosaicism.
    Dhamija R; Kirmani S; Wang X; Ferber MJ; Wieben ED; Lazaridis KN; Babovic-Vuksanovic D
    Am J Med Genet A; 2014 Sep; 164A(9):2356-9. PubMed ID: 24888332
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A novel dominant-negative FGFR1 variant causes Hartsfield syndrome by deregulating RAS/ERK1/2 pathway.
    Palumbo P; Petracca A; Maggi R; Biagini T; Nardella G; Sacco MC; Di Schiavi E; Carella M; Micale L; Castori M
    Eur J Hum Genet; 2019 Jul; 27(7):1113-1120. PubMed ID: 30787447
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dominant-negative kinase domain mutations in FGFR1 can explain the clinical severity of Hartsfield syndrome.
    Hong S; Hu P; Marino J; Hufnagel SB; Hopkin RJ; Toromanović A; Richieri-Costa A; Ribeiro-Bicudo LA; Kruszka P; Roessler E; Muenke M
    Hum Mol Genet; 2016 May; 25(10):1912-1922. PubMed ID: 26931467
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Endocrinological Features of Hartsfield Syndrome in an Adult Patient With a Novel Mutation of
    Kobayashi S; Tanigawa J; Kondo H; Nabatame S; Maruoka A; Sho H; Tanikawa K; Inui R; Otsuki M; Shimomura I; Ozono K; Hashimoto K
    J Endocr Soc; 2020 May; 4(5):bvaa041. PubMed ID: 32373773
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Use of Variant Maps to Explore Domain-Specific Mutations of FGFR1.
    Lansdon LA; Bernabe HV; Nidey N; Standley J; Schnieders MJ; Murray JC
    J Dent Res; 2017 Oct; 96(11):1339-1345. PubMed ID: 28825856
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Otorhinolaryngologic manifestations of Hartsfield syndrome: Case series and review of literature.
    Oliver JD; Menapace DC; Cofer SA
    Int J Pediatr Otorhinolaryngol; 2017 Jul; 98():4-8. PubMed ID: 28583501
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mosaicism in Hartsfield syndrome.
    Harris E; Richardson R; Annavarapu S; Tellez J; Butteriss D; Hannon T; Splitt M
    Eur J Med Genet; 2022 May; 65(5):104491. PubMed ID: 35338003
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mutations in fibroblast growth factor receptor 1 cause Kallmann syndrome with a wide spectrum of reproductive phenotypes.
    Pitteloud N; Meysing A; Quinton R; Acierno JS; Dwyer AA; Plummer L; Fliers E; Boepple P; Hayes F; Seminara S; Hughes VA; Ma J; Bouloux P; Mohammadi M; Crowley WF
    Mol Cell Endocrinol; 2006 Jul; 254-255():60-9. PubMed ID: 16764984
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel FGFR1 mutations in Kallmann syndrome and normosmic idiopathic hypogonadotropic hypogonadism: evidence for the involvement of an alternatively spliced isoform.
    Gonçalves C; Bastos M; Pignatelli D; Borges T; Aragüés JM; Fonseca F; Pereira BD; Socorro S; Lemos MC
    Fertil Steril; 2015 Nov; 104(5):1261-7.e1. PubMed ID: 26277103
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel FGFR1 and KISS1R Mutations in Chinese Kallmann Syndrome Males with Cleft Lip/Palate.
    Xu H; Niu Y; Wang T; Liu S; Xu H; Wang S; Liu J; Ye Z
    Biomed Res Int; 2015; 2015():649698. PubMed ID: 26199944
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical assessment and mutation analysis of Kallmann syndrome 1 (KAL1) and fibroblast growth factor receptor 1 (FGFR1, or KAL2) in five families and 18 sporadic patients.
    Sato N; Katsumata N; Kagami M; Hasegawa T; Hori N; Kawakita S; Minowada S; Shimotsuka A; Shishiba Y; Yokozawa M; Yasuda T; Nagasaki K; Hasegawa D; Hasegawa Y; Tachibana K; Naiki Y; Horikawa R; Tanaka T; Ogata T
    J Clin Endocrinol Metab; 2004 Mar; 89(3):1079-88. PubMed ID: 15001591
    [TBL] [Abstract][Full Text] [Related]  

  • 15. FGFR1 Analyses in Four Patients with Hypogonadotropic Hypogonadism with Split-Hand/Foot Malformation: Implications for the Promoter Region.
    Ohtaka K; Fujisawa Y; Takada F; Hasegawa Y; Miyoshi T; Hasegawa T; Miyoshi H; Kameda H; Kurokawa-Seo M; Fukami M; Ogata T
    Hum Mutat; 2017 May; 38(5):503-506. PubMed ID: 28087897
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel fibroblast growth factor receptor 1 mutations in patients with congenital hypogonadotropic hypogonadism with and without anosmia.
    Trarbach EB; Costa EM; Versiani B; de Castro M; Baptista MT; Garmes HM; de Mendonca BB; Latronico AC
    J Clin Endocrinol Metab; 2006 Oct; 91(10):4006-12. PubMed ID: 16882753
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Children with idiopathic hypogonadotropic hypogonadism: clinical data analysis and mutations analysis of KAL1 and FGFR1 gene].
    Qin M; Gong C; Qi Z; Wu D; Liu M; Gu Y; Cao B; Li W; Liang X
    Zhonghua Er Ke Za Zhi; 2014 Dec; 52(12):942-7. PubMed ID: 25619354
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hypogonadotropic Hypogonadism due to Novel FGFR1 Mutations.
    Akkuş G; Kotan LD; Durmaz E; Mengen E; Turan İ; Ulubay A; Gürbüz F; Yüksel B; Tetiker T; Topaloğlu AK
    J Clin Res Pediatr Endocrinol; 2017 Jun; 9(2):95-100. PubMed ID: 28008864
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genetics of congenital hypogonadotropic hypogonadism in Denmark.
    Tommiska J; Känsäkoski J; Christiansen P; Jørgensen N; Lawaetz JG; Juul A; Raivio T
    Eur J Med Genet; 2014 Jul; 57(7):345-8. PubMed ID: 24732674
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Two novel mutations in the gonadotropin-releasing hormone receptor gene in Brazilian patients with hypogonadotropic hypogonadism and normal olfaction.
    Costa EM; Bedecarrats GY; Mendonca BB; Arnhold IJ; Kaiser UB; Latronico AC
    J Clin Endocrinol Metab; 2001 Jun; 86(6):2680-6. PubMed ID: 11397871
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.